Author

E. Kumar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

S. Jiang· 2 shared A. Clear· 1 shared A. D'Avola· 1 shared A. F. Al Seraihi· 1 shared A. Melnick· 1 shared A. Yeomans· 1 shared D. Barisic· 1 shared F. Bewicke-Copley· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

S. Jiang

Author profile →

3 papers

Recent·Most cited

Investigation of Biomedical Cell Image Cryptography Based on RC4 Technique

S. Jiang, E. Kumar

The paper applies RC4, pixel shuffling, and steganography to encrypt biomedical cell images and evaluates their performance using cell viability, live/dead ratio, and morphology.

bioRxiv · Dec 29, 2023 · PreprintBioengineering

Investigation of Two-Component Hydrogel System for the Tissue Regeneration from Simulation

S. Jiang, E. Kumar

The paper develops a computational model to simulate a two-component hydrogel system's behavior and assesses its impact on cell growth for tissue regeneration.

bioRxiv · Dec 28, 2023 · PreprintBiochemistry

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas

J. A. Heward, L. Koniali, A. D'Avola, K. Close, A. Yeomans, M. Philpott, J. Dunford, T. Rahim, A. F. Al Seraihi, J. Wang, K. Korfi, S. Araf, S. Iqbal, F. Bewicke-Copley, E. Kumar, , J. Fitzgibbon

This study shows that inhibiting KDM5 demethylases restores H3K4 methylation and reactivates genes in KMT2D mutant lymphomas, offering a potential therapeutic strategy.

bioRxiv · Jun 30, 2020Cancer Biology